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Peritoneal adhesions describe a condition in which pathological bonds form between the omentum, the small and
large bowels, the abdominal wall, and other intra-abdominal organs. Different classification systems have been
proposed, but they do not resolve the underlying problem of ambiguity in the quantification and definition of
adhesions. We therefore propose a standardized classification system of adhesions to universalize their definition
based on the macroscopic appearance of adhesions and their diffusion to different regions of the abdomen. By
scoring with these criteria, the peritoneal adhesion index (PAI) can range from 0 to 30, unambiguously specifying
precise adhesion scenarios. The standardized classification and quantification of adhesions would enable different
studies to more meaningfully integrate their results, thereby facilitating a more comprehensive approach to the
treatment and management of this pathology.
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Peritoneal adhesions are pathological bonds that typi-
cally form between the omentum, the small and large
bowels, the abdominal wall, and other intra-abdominal
organs. These bonds may be a thin film of connective
tissue, a thick fibrous bridge containing blood vessels
and nerve tissue, or a direct adhesion between two organ
surfaces [1-3].
Depending on the etiology, peritoneal adhesions may be
classified as congenital or acquired (post-inflammatory or
post-operative) [4]. Some researchers assert that adhesions
could also be classified in three major groups: adhesions
formed at operative sites, adhesions formed de novo at
non-operative sites, and adhesions formed after the lysis
of previous adhesions [5]. Diamond et al. distinguished
types 1 and 2 of postoperative peritoneal adhesions. Type
1, or de novo adhesion formation, involves adhesions
formed at sites that did not have previous adhesions,* Correspondence: federico.coccolini@gmail.com
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reproduction in any medium, provided the orincluding Type 1A (no previous operative procedure at
the site of adhesion) and Type 1B (previous operative pro-
cedures at the site of adhesion). Type 2 involves adhesion
reformation, with two separate subtypes: Type 2A (no
operative procedure other than adhesiolysis at the site of
adhesion) and Type 2B (other operative procedures at the
site of adhesions) [6]. In 1990, Zhulke et al. proposed a
classification of adhesions based on their macroscopic ap-
pearance, which has since been used expressly for experi-
mental purposes [7]. These different classifications have
no impact on the underlying problem of post-operative/
post-inflammatory adhesions, which can be dramatic.
Moreover these classification systems do not engender an
unequivocal system of quantification and definition. Each
surgeon defines adhesions on an individual basis contin-
gent on the surgeon’s own experience and capability. At
present, it is not possible to analytically standardize adhe-
sions, even if such cases are a surgeon’s primary focus.
The prevalence of adhesions following major abdominal
procedures has been evaluated to be 63%-97% [8-12]. La-
paroscopic procedures compared to open surgery have
not demonstrated to significantly reduce the total numberal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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source of morbidity and are the most common cause of
intestinal obstruction [18,19], secondary female infertility,
and ectopic gestation [20,21]. They may also cause chronic
abdominal and pelvic pain [3,22,23]. Adhesive small bowel
obstruction is the most serious consequence of intra-
abdominal adhesions. Colorectal surgery has proven to be
the most common surgical cause of intra-abdominal adhe-
sions. Among open gynecological procedures, ovarian sur-
gery was associated with the highest rate of readmission
due to subsequent adhesions (7.5/100 initial operations)
[24]. Retrospective studies have shown that 32%-85% of
patients who require secondary abdominal surgery have
adhesion-related intestinal obstruction. Experimental and
clinical studies are not in agreement regarding the dif-
ferent rates of adhesion reformation following adhesio-
lysis performed via laparotomy or laparoscopy [25-27].PERITONEAL ADHESION IN
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Figure 1 Peritoneal adhesion index: by ascribing to each abdomen ar
will result in the PAI.Guidelines have been published regarding the manage-
ment of adhesive small bowel obstruction by the World
Society of Emergency Surgery (WSES) [28].
Adhesions require highly involved surgical intervention
and are a significant burden to health care systems. In the
United States, an epidemiological study demonstrated that
in 1988, 282,000 hospital admissions were attributable to
adhesion-related disorders, and the cost of in-patient
adhesiolysis procedures reached $1.18 billion [29]. An-
other study published in 1994, reported that 1% of all
admissions in the United States involved adhesiolysis,
costing $1.33 billion [30]. Adhesions and their associated
complications have piqued both medical and legal interest
in recent years [31]. Successful medical/legal claims in-
clude cases of bowel perforation following laparoscopic
resolution of adhesion, delays in the diagnosis of adhesion
obstruction of the small bowel, infertility resulting fromDEX:
esion grade score:
o adhesions
ilmy adhesions, blunt dissection
trong adhesions, sharp dissection
ery strong vascularized adhesions, sharp 
ection, damage hardly preventable 
ea an adhesion related score as indicated, the sum of the scores
Coccolini et al. World Journal of Emergency Surgery 2013, 8:6 Page 3 of 5
http://www.wjes.org/content/8/1/6adhesions, and visceral pain [31,32]. Currently, there is no
effective method for preventing adhesion formation or ref-
ormation [33]. A more comprehensive understanding of
the pathogenesis of adhesion formation at cellular and
molecular levels is needed to streamline preventative
treatment strategies [10].
The pathogenesis of adhesion formation involves three
important trauma-induced processes: (I) inhibition of
the fibrinolytic and extracellular matrix degradation sys-
tems [34,35]; (II) induction of an inflammatory response
involving the production of cytokines and growth factor-
β (TGF-β1), a key regulator of tissue fibrosis [36-38];
and (III) induction of tissue hypoxia following interrup-
tion of blood delivery to mesothelial cells and sub-
mesothelial fibroblasts, leading to increased expression
of hypoxia-induced factor-1α [39,40] and vascular endo-
thelial growth factor, responsible for collagen formation
and angiogenesis [31,41].
Several trials have examined the effects of systemic
and local application of a variety of drugs, including ste-
roids [41,42], non-selective and selective cyclooxygenase
inhibitors [43-47], heparin [48-50], 3-hydroxy-3-methyl-
glutaryl-CoA reductase inhibitors (statins) [51], and
tissue-plasminogen activator [52]. Different theoretical
approaches involving, for example, growth factors or the
neurokinin-1 receptor, have also been tested. Further,
the use of natural agents such as pollen and honey or
cold saline solutions has been explored in an effort to
reduce adhesion rates [53,54].
Local molecular therapies, including recombinant anti-
bodies and protein, have been employed with moderate
success [31]; these therapeutic agents work by correcting
aberrant molecular pathways involved in adhesion forma-
tion [31]. Local molecular therapy is inherently limited;
therefore an alternative strategy using gene therapy has re-
cently been employed to correct molecular aberrations
induced by surgical trauma [31]. In five studies based on
rat models, different vectors were used to express the-
rapeutic nucleic acids (transgenes or small interfering
RNAs) in peritoneal tissue [31,40,55-59].
However, no method has distinguished itself as the opti-
mal means of preventing adhesion formation [59]. Current
preventive approaches range from the use of physical bar-
riers to the administration of pharmacological agents, re-
combinant proteins and antibodies, and gene therapy, yet
they have all failed to consistently yield satisfactory results.
Single therapeutic strategies are typically unsuccessful in
preventing peritoneal adhesions due to the multi-factorial
nature of adhesion pathogenesis. Extensive literature on
the subject demonstrates both the complexity of the issue
and the myriad resources allocated to this condition, yet
few interdisciplinary studies have been conducted invol-
ving experts from different fields. At this time the medical
community only recognizes the “tip of the iceberg” andwill continue treating the condition inadequately until it is
more comprehensively explored.
We are in agreement with Hellebrekers et al. and believe
that additional prospective studies must be conducted to
examine adhesion formation in relation to factors of in-
flammation, coagulation, and fibrinolysis. To more effec-
tively integrate the findings of different studies, specific
attention should be paid to uniformity of measurement
(what, where, and when to measure) [60]. We therefore
suggest a regimented classification system for adhesions in
an effort to standardize their definition and subsequent
analysis. In this way, different surgeons in different treat-
ment centers can more effectively evaluate patients and
compare their conditions to past evaluations using a uni-
versal classification system (Figure 1). This classification is
based on the macroscopic appearance of adhesions and
their extent to the different regions of the abdomen. Using
specific scoring criteria, clinicians can assign a peritoneal
adhesion index (PAI) ranging from 0 to 30, thereby giving
a precise description of the intra-abdominal condition.
Standardized classification and quantification of adhesions
would enable researchers to integrate the results of diffe-
rent studies to more comprehensively approach the treat-
ment and management of adhesion-related pathology.
Furthermore, as asserted by other researchers [53], we
must encourage greater collaboration among basic, mate-
rial, and clinical sciences. Surgery is progressively beco-
ming more dependent on the findings of research in the
basic sciences, and surgeons must contribute by practicing
research routinely in a clinical setting. To further advance
surgical techniques, we must better understand the phy-
siopathology of surgically induced conditions.
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